Clinical Trial Update: Valproate Dose Reduction and Its Clinical Evaluation by Introducing Lamotrigine in Japanese Women With Epilepsy - Single Arm, Multicenter, and Open-label Study [Phase 4]

View source ↗

Summary

Phase 4, single-arm, open-label trial in Japanese women with epilepsy evaluating dose reduction of valproate with the addition of lamotrigine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy

Drugs mentioned

• Lamotrigine (lamotrigine)
• VALPROIC ACID (Valproic acid)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Epilepsy | Phase 4 | Status: COMPLETED | Results posted: 2016-02-01